Shenzhen, China

Kai Tian

This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignees: Mgi Tech Co., Ltd., Huawei Technologies Co., Limited. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kai Tian. Retrieved from https://idiyas.com/inventor/kai-tian-xeesvwl8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Nanjing, CN (2018)
  • Shenzhen, CN (2019 - 2021)

Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Kai Tian from Shenzhen, CN

Introduction

Kai Tian is an innovative inventor based in Shenzhen, China, renowned for his contributions to the field of nucleic acid library construction and sequencing. With a remarkable portfolio of three patents, Tian is focused on enhancing the efficiency and accuracy of sequencing technologies.

Latest Patents

Among Kai Tian's latest patents are two significant innovations:

1. **Vesicular adaptor and uses thereof in nucleic acid library construction and sequencing** - This patent details a vesicular adaptor and a single-chain cyclic library constructed using the adaptor. The library is designed for RNA sequencing and other sequencing platforms that rely on a single-stranded cyclic library. Noteworthy benefits include high throughput sequencing, high accuracy, and straightforward operations.

2. **Vesicular linker and uses thereof in nucleic acid library construction and sequencing** - Similar to his previous patent, this innovation involves a vesicular linker and a single-chain cyclic library. This library, too, serves RNA sequencing and offers advantages such as high throughput sequencing and operational simplicity.

Career Highlights

Kai Tian's work reflects a deep commitment to advancing scientific methodologies in sequencing technologies. His innovative approaches have garnered recognition within the industry, securing his position as a leading figure in research and development.

Collaborations

Throughout his career, Kai Tian has collaborated with esteemed colleagues such as Yuan Jiang and Xia Zhao. Their collective expertise contributes to the innovative atmosphere at MGI Tech Co., Ltd., where they work together to push the boundaries of what is possible in nucleic acid research.

Conclusion

In conclusion, Kai Tian's inventive work has pivotal implications for nucleic acid sequencing technologies. His patents demonstrate a profound dedication to enhancing the accuracy and efficiency of these processes, securing his place as an influential inventor in the contemporary scientific landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…